99 % of 100
In stock
599.9 Reward Points will be used to purchase this product

Buy this product and Earn 20.00 Pinnacle Points click here to login



For this product you will need: BACTERIOSTATIC WATER For reconstitution.

The chemicals/materials for sale here are intended for laboratory and research use only, unless otherwise explicitly stated. They are not intended for human ingestion or for use in products that may be ingested.


Tesamorelin is a man-made analog of growth hormone-releasing hormone (GHRH). It is composed of 44 amino acids, and its N-terminus is chemically modified by the addition of a trans-3-hexenoic acid group. This minor difference makes it resistant to cleavage by dipeptidyl aminopeptidase, thus making it more stable and extending its half-life.

Tesamorelin was approved by the FDA for the treatment of HIV-related lipodystrophy in 2010. Further, this synthetic peptide has been researched for its applications in cardiovascular diseases and dementia. At Pinnacle Peptides, tesamorelin for sale is exclusively available for research and educational institutions.


From Pubchem


Molecular Formula: C216H360N72O63S
Molecular Weight: 5006 g/mol
CAS number: 218949-48-5
PubChem CID: 56928011


As a GHRH analog, it binds to growth hormone releasing-hormone receptors in the anterior pituitary glands. This, in turn, activates the series of intracellular signaling, leading to the production and release of growth hormone. GH is a powerful anabolic hormone involved in many processes, including building muscle mass and repair. It acts on different cells, including liver cells, and stimulates the release of insulin-like growth factor-1 (IGF-1).

Pre-Clinical/Clinical Research

1. HIV-related Lipodystrophy

The use of highly active antiretroviral therapy among AIDS patients has been associated with the development of lipodystrophy. Lipodystrophy is characterized by the abnormal distribution of fat in the body, such as the accumulation of visceral adipose tissue in the abdomen. This can increase the risk of cardiovascular diseases and insulin resistance.

The use of recombinant human growth hormone has been approved by the FDA for the treatment of lipodystrophy. However, it requires large doses and might cause side effects, such as peripheral edema and carpal tunnel syndrome [1[. On the other hand, tesamorelin proved a safe and effective option for the treatment of HIV-associated lipodystrophy.

Research suggests it is four times more effective than all the other treatment options combined [2]. A phase III clinical trial was conducted to check the long-term safety and efficacy of tesamorelin. AIDS patients with lipodystrophy were randomized to receive either 2mg tesamorelin or placebo subcutaneously for 26 weeks. After that, patients originally on tesamorelin were switched to placebo and vice versa. The study concluded that tesamorelin was generally well-tolerated and effective. The decrease in visceral adipose tissue was sustained over 52 weeks. However, fat was reaccumulated upon the discontinuation of treatment [3].

2. Insulin Resistance

The use of recombinant growth hormone is associated with insulin resistance. One study was conducted to determine if tesamorelin also alters insulin sensitivity. 53 patients with type 2 diabetes were randomized to receive either tesamorelin (1mg, 2mg) or placebo for 12 weeks. The results didn’t find any significant difference between the two groups relative to insulin response throughout the study [4].

3. Cardiovascular Diseases

HIV patients on antiretroviral therapy are at higher risk of heart disease due to the accumulation of fat in the abdomen area. Along with HAART, the prevention of cardiovascular diseases is an important intervention for the long-term safety of patients. Research suggests that tesamorelin effectively reduces triglyceride, total cholesterol and LDL-C levels. 2mg of tesamorelin for 26 weeks has been shown to decrease 15% of the visceral adipose tissue which is equivalent to a 50mg reduction in triglyceride levels [5, 6].

4. Cognition

Research suggests that tesamorelin may help elderly patients suffering from dementia. One randomized double-blind placebo-controlled study found that GHRH analogs, including tesamorelin, increase the concentration of GABA (gamma-aminobutyric acid) and decrease myoinositol levels [7].

GABA is a neurotransmitter involved in regulating neuronal signalling in the hippocampus, a brain part responsible for episodic memory [8]. On the other hand, an increased concentration of myo-inositol is associated with an increased risk of dementia [9].

5. Peripheral Nerve Damage

Damage to peripheral nerves can occur as a consequence of uncontrolled diabetes, surgical procedures and injury. This might often affect a person's ability to move and perform daily tasks. Currently, there is no treatment to reverse the damage as nerve cells are difficult to regenerate. However, research suggests that growth hormone-based therapies, including tesamorelin, might improve the condition and boost the rate of healing [10].


Tesamorelin is a synthetic peptide that mimics the activity of GHRH. It is chemically modified to extend its half-life and duration of action. Research shows that it might improve peripheral nerve damage, prevent cardiovascular diseases and alleviate dementia. However, its FDA approval is limited to the treatment of HIV-associated lipodystrophy. We don’t support its unwarranted use and offer the option to purchase tesamorelin exclusively for research and experimentation. Only buy tesamorelin if you are a qualified researcher.


  1. Bedimo, R., Growth hormone and tesamorelin in the management of HIV-associated lipodystrophy. HIV AIDS (Auckl), 2011. 3: p. 69-79.
  2. Mangili, A., et al., Predictors of Treatment Response to Tesamorelin, a Growth Hormone-Releasing Factor Analog, in HIV-Infected Patients with Excess Abdominal Fat. PLoS One, 2015. 10(10): p. e0140358.
  3. Falutz, J., et al., Long-term safety and effects of tesamorelin, a growth hormone-releasing factor analogue, in HIV patients with abdominal fat accumulation. Aids, 2008. 22(14): p. 1719-28.
  4. Clemmons, D.R., S. Miller, and J.C. Mamputu, Safety and metabolic effects of tesamorelin, a growth hormone-releasing factor analogue, in patients with type 2 diabetes: A randomized, placebo-controlled trial. PLoS One, 2017. 12(6): p. e0179538.
  5. Falutz, J., et al., Metabolic Effects of a Growth Hormone–Releasing Factor in Patients with HIV. New England Journal of Medicine, 2007. 357(23): p. 2359-2370.
  6. Stanley, T.L., et al., Reduction in visceral adiposity is associated with an improved metabolic profile in HIV-infected patients receiving tesamorelin. Clinical infectious diseases, 2012. 54(11): p. 1642-1651..
  7. Friedman, S.D., et al., Growth Hormone–Releasing Hormone effects on brain γ-Aminobutyric acid levels in mild cognitive impairment and healthy aging. JAMA neurology, 2013. 70(7): p. 883-890.
  8. Jiménez-Balado, J. and T.S. Eich, GABAergic dysfunction, neural network hyperactivity and memory impairments in human aging and Alzheimer's disease. Semin Cell Dev Biol, 2021. 116: p. 146-159.
  9. Beacher, F., et al., Hippocampal Myo-inositol and Cognitive Ability in Adults With Down Syndrome: An In Vivo Proton Magnetic Resonance Spectroscopy Study. Archives of General Psychiatry, 2005. 62(12): p. 1360-1365.
  10. Tuffaha, S.H., et al., Therapeutic augmentation of the growth hormone axis to improve outcomes following peripheral nerve injury. Expert Opinion on Therapeutic Targets, 2016. 20(10): p. 1259-1265.

High Performance Liquid Chromatography (HPLC)


Mass Spectrometry (MS)


What is Tesamorelin?

Tesamorelin is a synthetic peptide used to treat excessive abdominal fat buildup, which is frequently seen in people with HIV-associated lipodystrophy. It stimulates the pituitary gland to release growth hormone (GH), acting as an analog of growth hormone-releasing hormone (GHRH). Tesamorelin helps to reduce visceral adipose tissue by raising GH levels, which enhances body composition. It has been demonstrated to be helpful in reducing abdomen fat in people with HIV-associated lipodystrophy and is normally delivered as a daily subcutaneous injection. However, for a correct diagnosis and advice on tesamorelin treatment, it's crucial to speak with a medical expert.

Tesamorelin Research

Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone (GHRH) that has mostly been investigated for its therapeutic effects on the buildup of excess abdominal fat in people with HIV-associated lipodystrophy. The study on tesamorelin is reviewed in this article, with an emphasis on its mechanisms of action, clinical efficacy, and related studies.

Mechanisms of Action

Tesamorelin works by attaching to the GHRH receptor in the pituitary gland and triggering the release of GH. Tesamorelin stimulates lipolysis and decreases visceral adipose tissue by raising GH levels. Additionally, it raises lipid profiles and insulin sensitivity, which helps to transform the body's composition for the better.

Clinical Efficacy

Reduction of Abdominal Fat:

Clinical trials have repeatedly demonstrated that tesamorelin treatment significantly reduces visceral adipose tissue in people with HIV-associated lipodystrophy. Improvements in waist circumference, waist-to-hip ratio, and general body fat distribution go hand in hand with these weight losses.

Metabolic Benefits:

The use of tesamorelin has been linked to improvements in metabolic indicators like lipid profiles and insulin sensitivity. Reduced levels of fasting glucose, insulin, triglycerides, and total cholesterol have been reported in studies, suggesting potential metabolic advantages beyond fat loss.

Quality of Life:

Tesamorelin has been demonstrated to enhance patient-reported outcomes and quality of life measures in addition to its physiological effects. According to studies, those undergoing tesamorelin treatment reported increases in their impression of their bodies, self-esteem, energy levels, and general well-being.

Clinical Research

TRIUMPH and THOSE Studies:

In the TRIUMPH and THOSE clinical studies, tesamorelin's effectiveness and safety were assessed in patients with lipodystrophy caused by HIV. These trials showed improvements in body composition, metabolic indices, and quality of life along with sizable decreases in visceral adipose tissue.

Other Studies:

Various populations, including postmenopausal women with abdominal obesity and people with nonalcoholic fatty liver disease (NAFLD), have been the focus of additional studies looking into the possible advantages of tesamorelin. These studies have also noted increases in metabolic markers and decreases in belly fat in these people.

Where to Buy Tesamorelin

Pinnacle Peptides is an online supplier that offers a variety of peptides, including tesamorelin. You can buy Tesamorelin online with genuine formulations for a relatively low-end price through our website. To ensure that your tests get the anticipated results, Pinnacle Peptides only offers tesramorelin for sale of the highest quality. As a result, scientists and researchers have come to rely on us to deliver the highest caliber goods throughout time. It is currently offered for sale in 5MG vials. However, this product's use is limited for direct human consumption. You can look up this item or other goods as well if you want to buy tesramorelin for your research. At our website, you'll discover the best quality peptides at the affordable prices.


The products we offer are intended for laboratory research use only. In purchasing any of these items, the customer acknowledges that there are risks involved with consumption or distribution of these products. These chemicals are NOT intended to use as food additives, drugs, cosmetics, household chemicals or other inappropriate applications. The listing of a material on this site does not constitute a license to its use in infringement of any patent. All of the products will be handled only by qualified and properly trained professionals. All customers represent and warrant that through their own review and study that they are fully aware and knowledgeable about the following: Government regulations regarding the use of and exposure to all products. The health and safety hazards associated with the handling of the products they purchase. The necessity of adequately warning of the health and safety hazards associated with any products. Pinnacle Peptides reserves the right to limit and/or deny sales of products to any unqualified individuals if we have reason to believe that misuse will occur.

Submit your review to Earn 50 Pinnacle Points click here to login

Write Your Own Review
You're reviewing:TESAMORELIN 5MG
Your Rating
DISCLAIMER: The products sold on this site are not a drug nor is it intended to treat, diagnose, cure or prevent any disease, nor is it meant for ANY cosmetic purpose. Pinnacle Peptides makes no claims of alleged beneficial properties of any product on this site if injected or ingested in any manner. Our Peptides are exclusively distributed legally within the laws of safe harbor for research peptides and are to be used for that purpose ONLY. If any country’s governing bodies feel we are in violation of their laws regarding peptides, we ask you contact us immediately via [email protected] so we may expeditiously rectify the situation.All customers represent and warrant that through their own review and study that they are fully aware and knowledgeable about the following:Their government regulations regarding the importation, purchase, possession and use of peptides. The health and safety hazards associated with the handling of peptides in a research setting. That peptides are NOT intended to be used as a food additive, drug, vitamin, supplement, cosmetic or any other inappropriate application. Such a sale would be otherwise denied.
Product List

Research Peptides

Research Chems

GLP-1 Peptides